News
Executives weigh in on current valuations and hype around AI in the healthcare sector and what it could mean for the future.
Virtual pediatric care company Clarity Pediatrics garners $14.5 million to expand into obesity care.
A handful of transformative transactions lifted 2025 merger and acquisitions totals, but dealmakers largely remained disciplined, prioritizing data-driven growth and digital platforms.
The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.
Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.